BRIEF-Cardiome Q1 loss per share $0.06
May 13 (Reuters) - Cardiome Pharma Corp :
* Anticipate our first commercial sales of XYDALBA this year and a larger commercial roll-out during 2017
* Cardiome reports first quarter 2016 financial results
* Q1 loss per share $0.06
* Q1 revenue $7.1 million versus I/B/E/S view $6.3 million
* Q1 earnings per share view $-0.21 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2016 All rights reserved.